Does VEDOLIZUMAB Cause Pulmonary embolism? 499 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 499 reports of Pulmonary embolism have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.7% of all adverse event reports for VEDOLIZUMAB.
499
Reports of Pulmonary embolism with VEDOLIZUMAB
0.7%
of all VEDOLIZUMAB reports
26
Deaths
260
Hospitalizations
How Dangerous Is Pulmonary embolism From VEDOLIZUMAB?
Of the 499 reports, 26 (5.2%) resulted in death, 260 (52.1%) required hospitalization, and 42 (8.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 499 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which VEDOLIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB